Yan, Zhenxian <br/><br/>
Efficacy and safety of tirofiban in high-risk patients with non-ST-segment elevation acute coronary syndromes.  [electronic resource] 

 -  Clinical cardiology  Sep 2009 
 - E40-4 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1932-8737 
<br/><br/><label>Standard No.: </label>10.1002/clc.20475  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Coronary Syndrome--drug therapy<br/>Aged<br/>Angioplasty, Balloon, Coronary--adverse effects<br/>Biomarkers--blood<br/>Creatine Kinase, MB Form--blood<br/>Double-Blind Method<br/>Electrocardiography<br/>Female<br/>Heart Diseases--blood<br/>Hemorrhage--chemically induced<br/>Humans<br/>Male<br/>Middle Aged<br/>Platelet Aggregation--drug effects<br/>Platelet Aggregation Inhibitors--adverse effects<br/>Prospective Studies<br/>Risk Assessment<br/>Thrombocytopenia--chemically induced<br/>Time Factors<br/>Tirofiban<br/>Treatment Outcome<br/>Troponin I--blood<br/>Tyrosine--adverse effects